Brind.

Exonate Ltd. is testing its lead candidate EXN407 for diabetic eye disease, involving Harvard Medical School and Schepens Eye Research Institute.

1 report, 1 independent Updated Jun 30

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Harvard Medical SchoolSchepens Eye Research Institute

Keep exploring

The entities involved

Harvard Medical School
medical school in Boston, Massachusetts
- Fatima Cody Stanford is now an associate professor at Harvard Medical School, coinciding with discussions on the wide variation in state-level obesity rates across the U.S.Thu 22:40

Coverage

Newest first; wire copies grouped

Jun 30finanznachrichten.de